Page last updated: 2024-09-04

tariquidar and amg 232

tariquidar has been researched along with amg 232 in 1 studies

Compound Research Comparison

Studies (tariquidar)	Trials (tariquidar)	Recent Studies (post-2010) (tariquidar)	Studies (amg 232)	Trials (amg 232)	Recent Studies (post-2010) (amg 232)
210	16	138	14	0	13

Protein Interaction Comparison

Protein	Taxonomy	tariquidar (IC50)	amg 232 (IC50)
Cellular tumor antigen p53	Homo sapiens (human)		0.0006
E3 ubiquitin-protein ligase Mdm2	Homo sapiens (human)		0.0006

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Grigoreva, T; Novikova, D; Romanova, A; Sagaidak, A; Tribulovich, V; Vorona, S	1

Other Studies

1 other study(ies) available for tariquidar and amg 232

Article	Year
Mdm2 inhibitors as a platform for the design of P-glycoprotein inhibitors. Bioorganic & medicinal chemistry letters, 2020, 09-15, Volume: 30, Issue:18 Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Computer Simulation; Drug Resistance, Multiple; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Heterocyclic Compounds, 3-Ring; Humans; Imidazoles; Isatin; Models, Molecular; Piperazines; Protein Binding; Proto-Oncogene Proteins c-mdm2; Quinolines; Structure-Activity Relationship	2020

Article

Year

Mdm2 inhibitors as a platform for the design of P-glycoprotein inhibitors.

Bioorganic & medicinal chemistry letters, 2020, 09-15, Volume: 30, Issue:18

Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Computer Simulation; Drug Resistance, Multiple; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Heterocyclic Compounds, 3-Ring; Humans; Imidazoles; Isatin; Models, Molecular; Piperazines; Protein Binding; Proto-Oncogene Proteins c-mdm2; Quinolines; Structure-Activity Relationship

2020